Tibet Cheezheng Tibetan Medicine Co., Ltd.

Simbol: 002287.SZ

SHZ

22.21

CNY

Tržna cena danes

  • 20.1008

    Razmerje P/E

  • 0.0000

    Razmerje PEG

  • 11.78B

    Kapaciteta MRK

  • 0.02%

    Donos DIV

Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287-SZ) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ). Prihodki podjetja prikazujejo povprečje 1032.811 M, ki je 0.139 % gowth. Povprečni bruto dobiček za celotno obdobje je 820.745 M, ki je 0.132 %. Povprečno razmerje bruto dobička je 0.780 %. Rast čistega dobička za lanskoletno poslovanje podjetja je 0.230 %, kar je enako 0.119 % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Tibet Cheezheng Tibetan Medicine Co., Ltd., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na 0. Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini 0.070. Na področju kratkoročnih sredstev 002287.SZ znaša 3194.367 v valuti poročanja. Velik del teh sredstev, natančneje 2366.48, je v denarju in kratkoročnih naložbah. V tem segmentu se je ob primerjavi s podatki za preteklo leto spremenil za 0.197%. Dolgoročne naložbe podjetja, ki sicer niso v središču njegovega zanimanja, znašajo 1056.533, če obstajajo, v valuti poročanja. To pomeni razliko v višini -349.738% glede na zadnje obdobje poročanja, kar odraža strateške premike družbe. Dolgoročni profil podjetja kaže skupni dolgoročni dolg v višini 1061.276 v valuti poročanja. Ta številka pomeni medletno spremembo v višini -0.089%. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo 3720.329 v valuti poročanja. Letna sprememba tega vidika je 0.115%. Podrobnejši pregled finančnih podatkov podjetja razkrije dodatne podrobnosti. Neto terjatve so ovrednotene na 663.538, zaloge na 156.33, dobro ime pa na 0, če obstaja. Celotna neopredmetena sredstva, če so prisotna, so ovrednotena z vrednostjo 351.62. Obveznosti in kratkoročni dolgovi so 9.79 oziroma {{short_term_deby}}. Celotni dolg je 1546.31, neto dolg pa je 1142.88. Druge kratkoročne obveznosti znašajo 437.68 in se dodajo k skupnim obveznostim 2334.43. Nazadnje se navedena zaloga vrednoti po vrednosti {{preffered_stock}}, če obstaja.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006

balance-sheet.row.cash-and-short-term-investments

10005.552366.51976.91850.6
1829.9
1379
395.5
386.4
457.9
352.4
283.9
525
515.5
521.1
761.1
827
214.9
174.8
307.3

balance-sheet.row.short-term-investments

8430.8819631539.31184
-13.2
32.3
-15.5
-18
-1.7
-1.6
-3.3
-3.4
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

3258.11663.5841.2629.6
1034.5
686.6
575.7
692.5
656.2
677.9
606.9
531.7
501.7
428.2
324.5
298.6
272
200.7
163.8

balance-sheet.row.inventory

642.83156.3127.8118.5
94.4
62
60.3
51.1
44.2
57.2
88.1
98.6
117.8
136.2
80.9
50.6
31.5
23.5
16.2

balance-sheet.row.other-current-assets

87.718246.6337.7
11.7
7.8
457.4
428.7
232.7
301.6
375.6
7.5
0.3
1.5
0.9
1.3
-13.5
0.2
0

balance-sheet.row.total-current-assets

14048.363194.43192.42936.4
2970.5
2135.4
1488.9
1558.7
1391.1
1389.1
1354.6
1162.8
1135.2
1087.1
1167.4
1177.6
504.8
399.2
487.4

balance-sheet.row.property-plant-equipment-net

5861.271651.61144.4821.4
577.8
545.7
488.4
404.2
322.9
347.6
290.8
245.9
180.8
155.5
127.7
94.6
101.5
98.8
28.6

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

1413.28351.6374.8399.3
176.2
45.7
47.7
49.3
50.8
85.1
85.3
76.1
75.6
76.4
23.5
24.4
24.4
15.5
10.1

balance-sheet.row.goodwill-and-intangible-assets

1413.28351.6374.8399.3
176.2
45.7
47.7
49.3
50.8
85.1
85.3
76.1
75.6
76.4
23.5
24.4
24.4
15.5
10.1

balance-sheet.row.long-term-investments

-561.91056.5-423.1-42.4
236.9
192.9
240.6
258
239.2
239.1
40.8
40.9
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

139.5739.429.126.7
26.7
8.8
5.6
9.7
4.1
2.8
2.7
7.8
2
0.5
1.4
0.8
0
0.1
0

balance-sheet.row.other-non-current-assets

5055.394.91568.91426.4
471
55.6
41.6
16.7
67.7
6.4
17.7
1.1
38.9
38
0
0
0.6
1.1
65

balance-sheet.row.total-non-current-assets

11907.613104.12694.22631.4
1488.6
848.8
823.9
737.9
684.6
681.1
437.3
371.8
297.4
270.5
152.6
119.8
126.5
115.5
103.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

25955.976298.55886.65567.8
4459.1
2984.1
2312.8
2296.6
2075.7
2070.1
1791.9
1534.6
1432.6
1357.5
1320
1297.3
631.3
514.7
591

balance-sheet.row.account-payables

744.05255.693.5184
50.2
20.2
8.9
9.2
6.4
34.8
19.3
8.1
5.4
7.9
6.4
6.2
3.4
2.7
5.9

balance-sheet.row.short-term-debt

3466.68478762.3610.8
306.4
300.2
0
220
116.5
130
0
0
0
0
0
0
3.2
0
0

balance-sheet.row.tax-payables

237.1255.661.937.7
43.2
42.3
39.9
16.8
19.8
36.6
37.7
-25.2
4.6
7.9
6.2
12.3
9.8
10.6
9.5

balance-sheet.row.long-term-debt-total

4253.11061.3934.4841.4
901.3
0
0
0
0
0
0
0
0
0
0
0
0
5
0

Deferred Revenue Non Current

754.86191.3167154.7
159.3
67.8
65.2
62.6
61.3
71.5
68.7
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

127.94---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

460.38437.7402.24.6
9.7
37.5
193.4
9.1
9.5
3.6
154.2
31.2
55
63.3
95.8
134.5
17.8
105.8
126.2

balance-sheet.row.total-non-current-liabilities

4959.41089.21138.91039.4
1062.6
68.1
65.3
62.6
61.3
71.5
68.7
47.1
20.6
8.8
8.5
12
7.9
10
2.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

21.9874.94.9
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

11067.612334.424992347.4
1824.5
722.2
267.5
402.8
324.3
419.1
242.2
86.3
80.9
80
110.7
152.7
99
118.4
134.4

balance-sheet.row.preferred-stock

471.98000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

2120.75530.2530.2530.3
530.3
530.2
406
406
406
406
406
406
406
406
406
406
365
365
40

balance-sheet.row.retained-earnings

8154.572104.11784.81667
1197.4
1015.5
975.6
853.6
740.8
645.2
568
493.5
427.9
368.4
323.9
294.7
149
26.2
304.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

2375.97631.3566.4507.4
440.1
259
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

1369.17454.7454.6464.3
450.3
440.9
647.7
617.4
587.7
559.9
530.2
509.3
487.3
470.4
457.8
442.4
17.1
4.1
110

balance-sheet.row.total-stockholders-equity

14492.443720.333363169
2618.2
2245.5
2029.3
1877
1734.5
1611.1
1504.2
1408.7
1321.2
1244.7
1187.7
1143.1
531.1
395.3
454.9

balance-sheet.row.total-liabilities-and-stockholders-equity

25955.976298.55886.65567.8
4459.1
2984.1
2312.8
2296.6
2075.7
2070.1
1791.9
1534.6
1432.6
1357.5
1320
1297.3
631.3
514.7
591

balance-sheet.row.minority-interest

202.0249.851.651.4
16.4
16.4
15.9
16.8
16.9
40
45.5
39.5
30.4
32.8
21.6
1.6
1.2
1
1.7

balance-sheet.row.total-equity

14694.463770.13387.73220.4
2634.6
2261.9
2045.2
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

25955.97---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

5660.633019.61116.21141.6
223.6
225.1
225.1
240
237.5
237.5
37.5
37.5
37.5
37.5
0
0
0
0
63.3

balance-sheet.row.total-debt

7726.781546.31696.71452.2
1207.7
300.2
0
220
116.5
130
0
0
0
0
0
0
3.2
5
0

balance-sheet.row.net-debt

6152.11142.91259.1785.6
-622.2
-1046.6
-395.5
-166.4
-341.4
-222.4
-283.9
-525
-515.5
-521.1
-761.1
-827
-211.7
-169.8
-307.3

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Tibet Cheezheng Tibetan Medicine Co., Ltd. opazno spremenil prosti denarni tok, ki se je spremenil v 54.464. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo 0, kar kaže na razliko -0.006 v primerjavi s prejšnjim letom. Zanimivo je, da je del delnic podjetja, natančneje 0, odkupilo podjetje samo. To dejanje je povzročilo spremembo v 0.000 v primerjavi s prejšnjim letom. Medtem pa obveznosti podjetja trenutno znašajo 9.79 v valuti poročanja. Družba je pri naložbenju porabila neto denarna sredstva v višini -589658311.000 v valuti poročanja. To je premik za 0.763 v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila 95.77, 0 in -201.8, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila 0.000, pri čemer je razlika v primerjavi z letom prej znašala 0.000. Poleg tega je podjetje namenilo -206.72 za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane -13.32, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006

cash-flows.row.net-income

585.9581.2469.5710.8
405.9
364.4
317.4
300.8
287.8
261.4
235.5
211.2
187.8
170.7
170.6
161.2
136
115.9
104.4

cash-flows.row.depreciation-and-amortization

7.5195.883.265.8
43.6
36
23.1
23
30.4
33.2
25.4
24
15.6
12.2
8.8
9.8
9.9
10
5.4

cash-flows.row.deferred-income-tax

-17.2-24.3-8.338.8
-16.2
-3
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0.87-168.33.64.9
9.6
14
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

3847.8-374.7521.1
-303
3.4
190.9
-90.8
91.9
-17.4
59.6
-49.9
-36.5
-194.6
-83.2
3.2
-79.8
-19
-70.4

cash-flows.row.account-receivables

41.9542-209.3369.7
-349.1
-102
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-28.46-28.5-10.6-24
-32.4
-1.9
-9.2
-6.9
-0.9
29.7
18.1
12.7
16.5
-55.3
-30.2
-19.2
-7.9
-7.4
-6.4

cash-flows.row.account-payables

09.8-146.4136.6
94.5
110.3
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

24.5124.5-8.338.8
-15.9
-3
200.1
-83.9
92.7
-47
41.5
-62.6
-53
-139.3
-53
22.4
-71.8
-11.6
-64.1

cash-flows.row.other-non-cash-items

320.18439.6112.5-306.5
98.8
-8.9
-32.1
-3.2
-20.9
-19.4
-9.5
13.2
2.8
0.1
0.7
1.4
-0.1
-15.5
-0.8

cash-flows.row.net-cash-provided-by-operating-activities

934.39000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-254.94-234.8-272.4-125.6
-339
-52.3
-128.9
-66.1
-179.9
-64.9
-81.5
-74.4
-61.6
-87
-57.3
-16.4
-23.8
-30.5
-13.9

cash-flows.row.acquisitions-net

-0.56-0.6-3.8-61.1
339.3
54.2
0
28.5
0
0
81.5
0
0
-1.4
0
0
0
-61.8
13.9

cash-flows.row.purchases-of-investments

-1450-1492.4-1418-3494.7
-830
-300
-1555
-1130
-620
-960
-712.5
0
0
-37.5
0
0
0
-31.6
-55.3

cash-flows.row.sales-maturities-of-investments

1063.161138.11355.91526
576.4
728.2
1588.4
924.8
701.2
851.6
375.9
0
0
87
0
0
0
101.3
11

cash-flows.row.other-investing-activites

-229.9803.80
-339
-52.3
0
0
-2.6
12
-81.5
0
0
-87
0.5
0
0
0.9
-13.9

cash-flows.row.net-cash-used-for-investing-activites

-642.34-589.7-334.5-2155.4
-592.3
377.9
-95.5
-242.7
-101.3
-161.3
-418.1
-74.4
-61.6
-125.8
-56.8
-16.4
-23.8
-21.8
-58.1

cash-flows.row.debt-repayment

-1492.91-201.8-637.8-341.8
-450
-300
-385
-259.5
-260
0
0
0
0
0
0
-3.2
-2
-2.7
0

cash-flows.row.common-stock-issued

-250.46000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

-0.5000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-219.61-206.7-340.5-195.5
-193.2
-167.1
-175.3
-162.1
-168.9
-157.9
-142.1
-125.9
-113.7
-113.7
-125.9
0
0
-205.3
0

cash-flows.row.other-financing-activites

1205.14-13.3795.1494.6
1482.2
633.3
297.8
337.8
190.3
79.1
8.1
11.3
0
11.3
20
456.1
0
1.4
0

cash-flows.row.net-cash-used-provided-by-financing-activities

-92.13-431.9-183.2-42.8
839
166.2
-262.5
-83.8
-238.6
-78.8
-134
-114.6
-113.7
-102.4
-105.9
452.9
-2
-206.6
0

cash-flows.row.effect-of-forex-changes-on-cash

1.140.63-0.7
-2.3
1.2
0
0
0
0
0
0
0
0
0
0
-42.1
-69.7
0

cash-flows.row.net-change-in-cash

215.99-34.1-229.1-1164
483.1
951.2
141.4
-96.7
49.3
17.7
-241.1
9.5
-5.7
-240
-65.9
612
-2
-206.6
-19.6

cash-flows.row.cash-at-end-of-period

1573.63403.4437.6666.6
1829.9
1346.8
395.5
254.1
350.8
301.5
283.9
525
515.5
521.1
761.1
827
-2
-206.6
-19.6

cash-flows.row.cash-at-beginning-of-period

1357.64437.6666.61830.6
1346.8
395.5
254.1
350.8
301.5
283.9
525
515.5
521.1
761.1
827
214.9
0
0
0

cash-flows.row.operating-cash-flow

934.39971.9285.71034.9
238.7
406
499.4
229.8
389.2
257.8
310.9
198.5
169.7
-11.7
96.9
175.6
65.9
91.4
38.5

cash-flows.row.capital-expenditure

-254.94-234.8-272.4-125.6
-339
-52.3
-128.9
-66.1
-179.9
-64.9
-81.5
-74.4
-61.6
-87
-57.3
-16.4
-23.8
-30.5
-13.9

cash-flows.row.free-cash-flow

679.46737.113.3909.3
-100.3
353.7
370.5
163.7
209.3
192.9
229.5
124.1
108
-98.7
39.6
159.1
42.1
60.9
24.6

Vrstica izkaza poslovnega izida

Prihodki Tibet Cheezheng Tibetan Medicine Co., Ltd. so se v primerjavi s prejšnjim obdobjem spremenili za -0.017%. Bruto dobiček podjetja 002287.SZ znaša 1627.9. Odhodki iz poslovanja podjetja so 1161.62 in so se v primerjavi s prejšnjim letom spremenili za 3.816%. Odhodki za amortizacijo znašajo 95.77, kar je -0.334% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini 1161.62, ki kaže 3.816% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo 0, kar pomeni 0.000% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša 0 in predstavlja -0.106% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so 466.28, ki kažejo -0.106% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je 0.230%. Čisti prihodki v zadnjem letu so znašali 581.2.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006

income-statement-row.row.total-revenue

2101.042010.32044.81770.5
1476.2
1402.7
1213.2
1053.2
968.4
994.7
950.1
969.5
934.3
789.2
523.6
469.3
413.5
339.3
267.9

income-statement-row.row.cost-of-revenue

349.53382.4324.1265.3
206.7
180.3
148
133.1
150
201
250.1
356.4
436.6
359.3
135.9
97.2
70.6
63.3
56.7

income-statement-row.row.gross-profit

1751.511627.91720.61505.1
1269.5
1222.4
1065.3
920
818.3
793.7
700.1
613.1
497.7
430
387.7
372
342.8
276
211.2

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

58---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

52.87---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

1004.63---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-3.150.87850.5
37.5
43.5
-3.7
2.4
38.5
18.3
53.3
38.4
15.9
7.7
19.9
13.4
3.8
8.8
7.2

income-statement-row.row.operating-expenses

1191.781161.61118.91007.3
846.6
853.9
744.5
605.6
566.6
542.7
465.2
388.9
298.5
245.8
243.5
231.8
218.2
187.4
121.9

income-statement-row.row.cost-and-expenses

1541.3115441443.11272.6
1053.3
1034.2
892.5
738.7
716.6
743.8
715.2
745.3
735
605
379.4
329
288.8
250.7
178.6

income-statement-row.row.interest-income

10.5413.11734.4
42.7
16.6
-0.4
3.4
2.9
4.4
4
11.4
10.8
11.7
10.8
0
8.3
4.2
0

income-statement-row.row.interest-expense

63.3363.156.453.4
19.5
1.8
7.5
3.9
3.1
0.6
3.8
0
0
0
0
-10
0.2
0.3
-6.7

income-statement-row.row.selling-and-marketing-expenses

1004.63---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

130.43176.2-2.3-2.3
-10.6
-0.3
29.6
9.6
62
40.4
51.2
33.7
23.6
18.7
29.7
22.4
12.5
28.9
15.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-3.150.87850.5
37.5
43.5
-3.7
2.4
38.5
18.3
53.3
38.4
15.9
7.7
19.9
13.4
3.8
8.8
7.2

income-statement-row.row.total-operating-expenses

130.43176.2-2.3-2.3
-10.6
-0.3
29.6
9.6
62
40.4
51.2
33.7
23.6
18.7
29.7
22.4
12.5
28.9
15.1

income-statement-row.row.interest-expense

63.3363.156.453.4
19.5
1.8
7.5
3.9
3.1
0.6
3.8
0
0
0
0
-10
0.2
0.3
-6.7

income-statement-row.row.depreciation-and-amortization

61.2795.8143.9111
53.1
33.8
23.1
23
30.4
33.2
25.4
24
15.6
12.2
8.8
9.8
9.9
10
5.4

income-statement-row.row.ebitda-caps

598.17---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

569.73466.3521.5790.2
457.3
401.5
354
321.7
275.3
273.1
232.9
219.7
207
195.3
154.1
149.8
133.4
109.1
97.3

income-statement-row.row.income-before-tax

672.15642.5519.2787.9
446.7
401.3
350.3
324
313.8
291.4
286.1
257.9
222.8
202.9
173.9
162.7
137.1
117.6
104.4

income-statement-row.row.income-tax-expense

73.0465.249.777.1
40.8
36.9
32.9
23.3
26
30
50.6
46.7
35
32.3
3.3
1.5
1.2
1.6
0.1

income-statement-row.row.net-income

585.9581.2472.5715.9
404
364.3
318.8
300.8
289.9
264.9
237.5
213.4
190.2
170.7
170.5
160.8
135.8
115.8
106

Pogosto zastavljeno vprašanje

Kaj je Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) skupna sredstva?

Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) skupna sredstva so 6298478593.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so 1150739074.000.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.834.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je 1.281.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je 0.279.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so 0.271.

Kaj je Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je 581198850.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 1546314759.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 1161615874.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 357241866.000.